Patent US4981471A successfully refreshed from Google Patents.
Patent US4118470A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4118470A Expired / Lapsed US ⏱️ 0.0 years remaining

Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product

Assignee: Wyeth Holdings LLC
•
Filing: 1977-05-05
•
Granted: 1978-10-03
•
Expires: 1997-05-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product of (A) a polyglycolic acid composition and (B) a polyester of diglycolic acid and an unhindered glycol and to the process of preparing the same and the use of said polymeric reaction product as a sterile surgical element and as a device for the controlled continuous administration of a predetermined dosage of a drug to a living animal.

Inventors

  • 👤 Donald James Casey
  • 👤 Martin Epstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:58
CPC Classifications
C; C08; C08G; C08G63/00; C08G63/66; C08G63/664; A; A61; A61K; A61K9/00; A61K9/70; A61K9/7007; A61L; A61L15/00; A61L15/07; A61L15/12; A61L15/16; A61L15/42; A61L15/64; A61L17/00; A61L17/06; A61L17/10; A61L17/12

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 112 words
A device for the controlled continuous administration of a predetermined dosage of a drug to a living animal comprising the polymeric reaction product of (A) a polyglycolic acid composition and (B) a polyester of diglycolic acid and an unhindered glycol; wherein the amount of (B) used is between about 2% and 50%, by weight, based on the total weight of (A) and (B); wherein (A), before reaction with (B), has a molecular weight of at least 30,000 and (B), before reaction with (A), has a molecular weight sufficiently high so as to provide a polymeric material possessing self-supporting film-forming properties, which has dispersed uniformly throughout said polymeric reaction product, a drug formulation.
Claim 2
Independent Claim 112 words
A device for the controlled continuous administration of a predetermined dosage of a drug to a living animal comprising the polymeric reaction product of (A) a polyglycolic acid composition and (B) a polyester of diglycolic acid and an unhindered glycol; wherein the amount of (B) used is between about 2% and 50%, by weight, based on the total weight of (A) and (B); wherein (A), before reaction with (B), has a molecular weight of at least 30,000 and (B), before reaction with (A), has a molecular weight sufficiently high so as to provide a polymeric material possessing self-supporting film-forming properties, which has dispersed uniformly throughout said polymeric reaction product, a drug formulation.
Claim 3
Dependent Claim 13 words
A device according to claim 1 in the form of a self-supporting film.

References Cited (Backward Citations)

US3991766A Cited
US3997512A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-10-02 1982-04-03 1982-10-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-10-02 1986-04-03 1986-10-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-10-02 1990-04-03 1990-10-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag